Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes

Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes

Abstract This observational claims-linked survey study assessed the prevalence of and risk factors for suboptimal asthma control and healthcare utilization in adults with asthma receiving fixed-dose combination (FDC) inhaled corticosteroid/long-acting β2-agonist (ICS/LABA). Commercially insured adul...

Full description

Bibliographic Details
Main Authors: Shiyuan Zhang, John White, Alyssa Goolsby Hunter, David Hinds, Andrew Fowler, Frances Gardiner, David Slade, Sharanya Murali, Wilhelmine Meeraus
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:npj Primary Care Respiratory Medicine
Online Access:https://doi.org/10.1038/s41533-023-00336-9

Internet

https://doi.org/10.1038/s41533-023-00336-9

Similar Items